Main Menu

Friday, December 29th, 2017


7 Ways Spending Time Alone Will Change Your Life

Finally, the door closed and the noise stopped. I was in my bedroom, my own bedroom, with the lights turned perfectly low and no one else around. It was the holidays, and I had just spent nearly two days straight with family, passing around casserole and opening presents and trying not to scream when I realized there was no escape, at least not until the cut-out cookies had been served. But now, I had this. Time alone. The relief felt as real as a drug carrying me away to bliss. Don’t get meRead More

7 Ways Spending Time Alone Will Change Your Life

4. You’ll solve problems and optimize your life. When you don’t have to make small talk with grandma or listen as your coworker extols the virtues of his latest Amazon purchase, your mind is freed up. You start imagining a better way to organize the yearly training seminar you run at work. You pull out a deeper meaning behind a recent experience. You think about everyone you’ve ever dated, what qualities drew you to them, what that says about you as a person, and how you’ll use that information toRead More

FDA Clears First Nebulized LAMA Inhaler for COPD

The US Food and Drug Administration (FDA) has approved glycopyrrolate inhalation solution 25 mcg twice daily (Lonhala Magnair, Sunovion Pharmaceuticals) for maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Lonhala Magnair is the first nebulized long-acting muscarinic antagonist (LAMA) approved by the FDA for the treatment of COPD. It is the first time the Magnair eFlow technology system, developed by PARI Pharma GmbH, has been used, Sunovion said in a news release. “This technology is a virtually silent, portable, closed system nebulizerRead More